Plant Factories as Biopharmac's Production
نویسندگان
چکیده
منابع مشابه
Cyanobacteria as Cell Factories to Produce Plant Secondary Metabolites
Cyanobacteria represent a promising platform for the production of plant secondary metabolites. Their capacity to express plant P450 proteins, which have essential functions in the biosynthesis of many plant secondary metabolites, makes cyanobacteria ideal for this purpose, and their photosynthetic capability allows cyanobacteria to grow with simple nutrient inputs. This review summarizes the a...
متن کاملPlants as factories for the Production of Pharmaceutical recombinant proteins
Nowadays, transgenic plants are used as an attractive alternative to produce recombinant pharmaceutical proteins. Recombinant proteins such as vaccines and antibodies can be produced in plants via two systemes: stable genetic transformation and transient expression. Stable transformation is included of integrating a gene into the plant nuclear or chloroplast genome. The transient expression can...
متن کاملFilamentous fungi as cell factories for heterologous protein production.
Filamentous fungi have been used as sources of metabolites and enzymes for centuries. For about two decades, molecular genetic tools have enabled us to use these organisms to express extra copies of both endogenous and exogenous genes. This review of current practice reveals that molecular tools have enabled several new developments. But it has been process development that has driven the final...
متن کاملCharmonium production at neutrino factories
At existing and planned neutrino factories (high energy and high intensity neutrino beam facilities) precision studies of QCD in neutrino-nucleon interactions are a realistic opportunity. We investigate charmonium production in fixed target neutrino experiments. We find that J/ψ production in neutrinonucleon collision is dominated by the color octet S1 NRQCD matrix element in a neutral current ...
متن کاملCell factories for insulin production
The rapid increase in the number of diabetic patients globally and exploration of alternate insulin delivery methods such as inhalation or oral route that rely on higher doses, is bound to escalate the demand for recombinant insulin in near future. Current manufacturing technologies would be unable to meet the growing demand of affordable insulin due to limitation in production capacity and hig...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Current Trends in Biomedical Engineering & Biosciences
سال: 2017
ISSN: 2572-1151
DOI: 10.19080/ctbeb.2017.06.555682